Education
About Us
Working with TipRanks
Follow Us
Universe Pharmaceuticals (UPC)
NASDAQ:UPC
UPC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.51 - $600.12
Previous CloseN/A
Volume250.22K
Average Volume (3M)150.40K
Market Cap
$2.50M
Enterprise Value-$38.12M
Total Cash (Recent Filing)$47.27M
Total Debt (Recent Filing)$7.73M
Price to Earnings (P/E)―
Beta1.05
Next Earnings
Aug 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding563,338
10 Day Avg. Volume254,355
30 Day Avg. Volume150,399
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap-15.24
Enterprise Value/Revenue-1.98
Enterprise Value/Gross Profit-6.36
Enterprise Value/Ebitda-21.08
Forecast
1Y Price Target
$4.50Price Target Upside1.35% Upside
Rating ConsensusHold
Number of Analyst Covering0
Universe Pharmaceuticals News
UPC FAQ
What was Universe Pharmaceuticals’s price range in the past 12 months?
Universe Pharmaceuticals lowest stock price was $2.51 and its highest was $600.12 in the past 12 months.
What is Universe Pharmaceuticals’s market cap?
Universe Pharmaceuticals’s market cap is $2.50M.
When is Universe Pharmaceuticals’s upcoming earnings report date?
Universe Pharmaceuticals’s upcoming earnings report date is Aug 04, 2025 which is 56 days ago.
How were Universe Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Universe Pharmaceuticals overvalued?
According to Wall Street analysts Universe Pharmaceuticals’s price is currently Undervalued.
Does Universe Pharmaceuticals pay dividends?
Universe Pharmaceuticals does not currently pay dividends.
What is Universe Pharmaceuticals’s EPS estimate?
Universe Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Universe Pharmaceuticals have?
Universe Pharmaceuticals has 563,338 shares outstanding.
What happened to Universe Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Universe Pharmaceuticals?
Currently, no hedge funds are holding shares in UPC
Company Description
Universe Pharmaceuticals
Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
Technical Analysis
Ownership Overview
―
Insiders
0.07% Mutual Funds
6.51% Other Institutional Investors
93.49% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---